Inj melpha hydroch nos 50 mg
Products billed under this code include Melphalan.
Payment limit per 50 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under J9245
From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Melphalan | Heritage Pharmaceuticals Inc. | 23155-0355-41 | 1 | $90.032 |
| Melphalan | Sagent Pharmaceuticals | 25021-0258-61 | 1 | $90.032 |
| Melphalan | Dr. Reddy's Laboratories Inc. | 43598-0392-48 | 1 | $90.032 |
| Melphalan | Actavis Pharma, Inc. | 45963-0686-02 | 1 | $90.032 |
| Melphalan | FreseniUS Kabi USA, LLC | 63323-0760-20 | 1 | $90.032 |
| Melphalan | Mylan Institutional LLC | 67457-0195-01 | 1 | $90.032 |
| Melphalan | Mylan Institutional LLC | 67457-0215-01 | 1 | $90.032 |
| Melphalan | Xiromed, LLC | 70700-0278-97 | 1 | $90.032 |
| Melphalan | Athenex Pharmaceutical Division, LLC | 70860-0214-61 | 1 | $90.032 |
| Melphalan | Meitheal Pharmaceuticals Inc. | 71288-0132-90 | 1 | $90.032 |
Show all 13 products
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Melphalan | Fosun Pharma USA Inc. | 72266-0128-01 | 1 | $90.032 |
| Melphalan | Dr. Reddy's Laboratories Inc. | 75907-0112-11 | 1 | $90.032 |
| Melphalan | Avenacy Inc. | 83634-0202-61 | 1 | $90.032 |
Every quarter
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $90.032 | −$14.866 | 50 MG | Inj melpha hydroch nos 50 mg | v1, posted September 17, 2026 |
| 3Q26 | $104.898 | −$15.77 | 50 MG | Inj melpha hydroch nos 50 mg | v1, posted September 15, 2026 |
| 2Q26 | $120.668 | +$33.726 | 50 MG | Inj melpha hydroch nos 50 mg | v1, posted September 15, 2026 |
| 1Q26 | $86.942 | −$8.959 | 50 MG | Inj melpha hydroch nos 50 mg | v1, posted September 15, 2026 |
| 4Q25 | $95.901 | −$12.129 | 50 MG | Inj melpha hydroch nos 50 mg | v1, posted September 8, 2026 |
| 3Q25 | $108.03 | −$49.072 | 50 MG | Inj melpha hydroch nos 50 mg | v1, posted March 10, 2026 |
| 2Q25 | $157.102 | +$23.408 | 50 MG | Inj melpha hydroch nos 50 mg | v1, posted March 10, 2026 |
| 1Q25 | $133.694 | −$19.842 | 50 MG | Inj melpha hydroch nos 50 mg | v1, posted December 19, 2025 |
| 4Q24 | $153.536 | −$1.795 | 50 MG | Inj melpha hydroch nos 50 mg | v1, posted June 11, 2025 |
| 3Q24 | $155.331 | −$12.429 | 50 MG | Inj melpha hydroch nos 50 mg | v1, posted June 11, 2025 |
| 2Q24 | $167.76 | +$19.739 | 50 MG | Inj melpha hydroch nos 50 mg | v1, posted March 11, 2025 |
| 1Q24 | $148.021 | −$28.231 | 50 MG | Inj melpha hydroch nos 50 mg | v1, posted December 19, 2024 |
| 4Q23 | $176.252 | +$22.064 | 50 MG | Inj melpha hydroch nos 50 mg | v1, posted October 10, 2024 |
| 3Q23 | $154.188 | −$32.326 | 50 MG | Inj melpha hydroch nos 50 mg | v1, posted June 5, 2024 |
| 2Q23 | $186.514 | −$34.147 | 50 MG | Inj melpha hydroch nos 50 mg | v1, posted February 23, 2024 |
| 1Q23 | $220.661 | −$76.441 | 50 MG | Inj melpha hydroch nos 50 mg | v1, posted December 6, 2023 |
| 4Q22 | $297.102 | +$115.596 | 50 MG | Inj melpha hydroch nos 50 mg | v1, posted June 22, 2023 |
| 3Q22 | $181.506 | −$5.348 | 50 MG | Inj melpha hydroch nos 50 mg | v1, posted June 9, 2023 |
| 2Q22 | $186.854 | −$10.604 | 50 MG | Inj melpha hydroch nos 50 mg | v1, posted December 14, 2022 |
| 1Q22 | $197.458 | −$10.951 | 50 MG | Inj melpha hydroch nos 50 mg | v1, posted June 8, 2022 |
| 4Q21 | $208.409 | −$15.988 | 50 MG | Inj melpha hydroch nos 50 mg | v1, posted June 2, 2022 |
| 3Q21 | $224.397 | −$100.339 | 50 MG | Inj melpha hydroch nos 50 mg | v1, posted June 2, 2022 |
| 2Q21 | $324.736 | +$95.948 | 50 MG | Inj melpha hydroch nos 50 mg | v1, posted March 1, 2022 |
| 1Q21 | $228.788 | – | 50 MG | Inj melpha hydroch nos 50 mg | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.
CMS source files
- 4Q26: 2026-09-17_october-2026-medicare-part-b-payment-limit-files-final.zipposted September 17, 2026
- 4Q26: 2026-09-17_october-2026-ndc-hcpcs-crosswalk-final.zipposted September 17, 2026
- 3Q26: 2026-09-15_july-2026-medicare-part-b-payment-limit-files.zipposted September 15, 2026
- 2Q26: 2026-09-15_april-2026-medicare-part-b-payment-limit-files-final-file.zipposted September 15, 2026
- 1Q26: 2026-09-15_january-2026-medicare-part-b-payment-limit-files.zipposted September 15, 2026
- 4Q25: 2026-09-08_october-2025-asp-pricing-final-file.zipposted September 8, 2026
- 3Q25: 2026-03-10_july-2025-asp-pricing-file.zipposted March 10, 2026
- 2Q25: 2026-03-10_april-2025-asp-pricing-file.zipposted March 10, 2026
- 1Q25: 2025-12-19_january-2025-asp-pricing-file-03-11-25-final-file.zipposted December 19, 2025
- 4Q24: 2025-06-11_october-2024-asp-pricing-file.zipposted June 11, 2025
- 3Q24: 2025-06-11_july-2024-asp-pricing-file.zipposted June 11, 2025
- 2Q24: 2025-03-11_april-2024-asp-pricing-file.zipposted March 11, 2025
- 1Q24: 2024-12-19_january-2024-asp-pricing-file.zipposted December 19, 2024
- 4Q23: 2024-10-10_october-2023-asp-pricing-file.zipposted October 10, 2024
- 3Q23: 2024-06-05_july-2023-asp-pricing-file.zipposted June 5, 2024
- 2Q23: 2024-02-23_april-2023-asp-pricing-file.zipposted February 23, 2024
- 1Q23: 2023-12-06_january-2023-asp-pricing-file.zipposted December 6, 2023
- 4Q22: 2023-06-22_october-2022-asp-pricing-file.zipposted June 22, 2023
- 3Q22: 2023-06-09_july-2022-asp-pricing-file.zipposted June 9, 2023
- 2Q22: 2022-12-14_april-2022-asp-pricing-file.zipposted December 14, 2022
- 1Q22: 2022-06-08_january-2022-asp-pricing-file.zipposted June 8, 2022
- 4Q21: 2022-06-02_october-2021-asp-pricing-file.zipposted June 2, 2022
- 3Q21: 2022-06-02_july-2021-asp-pricing-file.zipposted June 2, 2022
- 2Q21: 2022-03-01_april-2021-asp-pricing-file.zipposted March 1, 2022
- 1Q21: 2021-12-10_january-2021-asp-pricing-file.zipposted December 10, 2021